wp-blogs

Empowering Dr Simone Sleep’s Advances in 3D Photobiomodulation Research with Gelomics’ Technology

Written by Alex Whitchurch | Mar 20, 2026 12:06:44 AM

From Inconsistent PBM Results to a Reproducible 3D Workflow

Dr Simone Sleep on Standardising Photobiomodulation in 3D

When Dr Simone Sleep first entered the world of photobiomodulation, the science seemed full of possibilities. Yet the results, scattered and uneven, rarely agreed.

“At Griffith University, our focus has been on understanding how PBM influences mitochondrial function in human dental stem cells.  However, one of the primary challenges in the field is inconsistency. Different laboratories report varying outcomes, much of which can be attributed to differences in model systems.” - Dr Sleep

Working within the School of Medicine and Dentistry at Griffith University, Simone, together with Professor Roy George, Professor Deanne Hryciw, and Professor Praveen Arany, sought to address a fundamental translational challenge:

 

How do you standardise PBM dose–response in a system that actually reflects native dental tissue?

The Problem: 2D Assays Weren’t Translating

Most high-throughput screening platforms are designed for 2D cultures. They offer convenience, but the world they create is flat, missing oxygen gradients, the resistance of real tissue, and the slow movement of molecules through a living matrix.

“For tissue regeneration, including dentin and bone, diffusion and oxygen tension are critical. We required a three-dimensional (3D) model that more accurately represented native tissue while remaining compatible with our Seahorse XFe96 metabolic platform.” - Dr Sleep

Translating a 2D workflow into a 3D system was not straightforward. New complications emerged, each persistent.

  • Uneven diffusion through hydrogels
  • Poor spheroid integrity
  • Inconsistent crosslinking
  • Loss of assay reliability

The search was for a matrix with the right balance: soft enough to mimic living tissue, strong enough to maintain its shape, and capable of meeting the demands of high-throughput assays.

Building a Controlled 3D System

Progress came through careful pairing of a biological model and steady control of the matrix.  Using human dental pulp stem cells cultured under hypoxic (~5% O₂), xeno-free conditions, the team developed a high-throughput 3D spheroid workflow inside LunaGel™. Using a hydrogel was not enough. What mattered was shaping it and tuning its properties until it responded as needed.

“With LunaGel™ and the LunaCrosslinker™, we could consistently tune stiffness to around ~3.5 kPa,” Dr Sleep explains. “That balance was critical - firm enough to maintain spheroid integrity, but permissive enough for small-molecule diffusion during Seahorse assays.”

With control over stiffness and careful timing during the mitochondrial stress test, responses that had once been hidden began to surface. The effects of PBM, previously blurred by diffusion limits, became clearer.

What Changed in the Data

Once optimised, the workflow adhered to a defined structure:

  • Encapsulation and crosslinking of hDPSCs in LunaGel™
  • Spheroid formation over ~7 days
  • Verified PBM delivery (including real power measurements at the well)
  • Seahorse XFe96 mitochondrial stress testing with diffusion-adjusted timing
  • Post-assay protein normalisation using the Cell Recovery Kit

The Results?

The team observed clear, dose- and time-dependent PBM effects on both basal and maximal respiration, which were not reproducible under 2D conditions.

Matrix optimisation and diffusion testing demonstrated that stiffness directly influenced modulator entry. Softer matrices facilitated more efficient diffusion, whereas stiffer matrices slowed metabolic response curves. These insights are critical for the accurate interpretation of mitochondrial data.

“The combination of stiffness tuning and Seahorse timing adjustments was decisive,”  Dr Sleep notes. “It allowed us to reveal PBM-dependent mitochondrial changes in 3D that simply weren’t visible in 2D systems.”

Figure: OCR response over time across matrices with different crosslinking durations, illustrating how matrix stiffness influences diffusion dynamics and mitochondrial readouts in 3D.

Impact on Efficiency and Reproducibility

Beyond the scientific findings, the workflow enhanced experimental efficiency.

The system:

  • Reduced variability through standardised gelation
  • Enabled consistent hypoxic, human-serum culture conditions
  • Converted a traditionally 2D-biased platform into a scalable 3D assay
  • Maintained high throughput without sacrificing biological relevance

“Ease of use was important. We saved setup time, and once optimised, the workflow was robust and reproducible.” - Dr Sleep

For translational research, reproducibility is essential. A stable 3D readout enables rational PBM dose selection and speeds the development of clinically relevant protocols.

 

Advice for Researchers Moving into 3D

Dr Sleep emphasises that successful 3D optimisation requires careful planning.

“Most high-throughput instruments were designed for 2D applications. It is necessary to plan a focused 3D optimisation phase.”

Her recommendations:

  • Pilot seeding density (≈1.5–2 × 10⁶ cells/mL)
  • Optimise LunaGel™ stiffness (~3.5 kPa typical)
  • Verify modulator diffusion timing in Seahorse cycles
  • Measure real delivered light at the well and report full PBM parameters

“Once optimised, the system is highly effective. Combining LunaGel™ with real-time mitochondrial stress testing provides a level of insight into PBM bioenergetics that was previously unattainable.”

Moving from Experimental Promise to Translational Confidence

Dr Simone Sleep’s work shows that the transition from 2D to 3D is not just an increase in complexity, but an exercise in achieving precise control.

By standardising matrix stiffness, diffusion timing, hypoxic conditions, and reporting parameters, her team established a reproducible 3D metabolic workflow capable of generating clinically relevant PBM insights.

For researchers at the intersection of regenerative medicine and metabolic modulation, structured 3D systems have become foundational rather than optional.